In March 2025, the company declared new plans for just a direct-to-buyer featuring of its Wegovy weight loss drug. The company recognized a new pharmacy, termed NovoCare, which would demand customers $499 each month for usage of the drug, less than 50 % the price of the drug by means of other pharmaceutical distribution networks.[53]Novo Nordisk is